Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck CancerRobert L. Ferris, Julie E. Bauman, Brian J Karlovits et al.|Clinical Cancer Research|2022Cited by 32
Phase 1 study of EGFR‐antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlativesJulie E. Bauman, Athanassios Argiris, Umamaheswar Duvvuri et al.|Cancer|2018Cited by 14
Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and the anti-CTLA-4 monoclonal antibody (mAb) ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC).Julie E. Bauman, Robert L. Ferris, William E. Gooding et al.|Journal of Clinical Oncology|2014Cited by 11
Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC)Julie E. Bauman, Dwight E. Heron, Robert L. Ferris et al.|Annals of Oncology|2016Cited by 8